Matthew Kane
Signal active
Co-Founder & Chief Executive Officer
Bio
Matt Kane is the CEO and co-founder of Precision BioSciences, a privately held gene editing biotech that uses the therapeutic grade editing platform, ARCUS. Matt has led Precision since its inception in 2006 and serves on Precision’s Board. He has over fifteen years of experience in the life sciences industry and was formerly with Suros Surgical Systems, later acquired by Hologic. When he isn’t working, you can find Matt enjoying time with his wife and daughters, hiking with his dogs, or stuck under a squat bar. He received his B.S. and M.S. from the Rose-Hulman Institute of Technology, and holds an MBA from Duke University.
Location
Raleigh, North Carolina, United States, North America
Social
Primary Organization
Precision BioSciences
Founded
2006
Employees
101-250
Industry
Biotechnology, Health Care, Medical, Genetics
Jobs history
2
Tune Therapeutics
Chief Executive Officer
Invalid date - Current
Tune Therapeutics
Board Member
Invalid date - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Matthew Kane is the Co-Founder & Chief Executive Officer at Precision BioSciences, based in United States, North America. With a background in Biotechnology, Matthew Kane has a rich history of leadership and innovation. Matthew Kane studied MBA Health Sector Management @ Duke University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
N/A
Number of investment
1
Number of exits
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
0
There is no partner investment available on this profile
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.